The Association Between Physical Sensations and Thinking Styles
NCT ID: NCT03233542
Last Updated: 2023-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
87 participants
INTERVENTIONAL
2017-09-18
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neural Effects of Cognitive-behaviour Therapy in Panic Disorder
NCT03251235
Mechanisms of Panic Disorders Treatment
NCT01323556
Threat-Avoidance Learning in Anxiety Patients
NCT02336802
Effect of Cognitive-behavior Therapy on Fear Responses to Body Symptoms in Patients With Panic Disorder
NCT04568109
Physical Activity and Cognitive Behavioural Therapy in Panic Disorder
NCT01788800
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Panic Disorder: CBT
Participants with Panic Disorder randomized to this arm will receive a manualised Cognitive Behaviour Therapy (CBT) treatment for Panic Disorder, delivered in the outpatient psychotherapy centre of the Department of Clinical Psychology and Psychotherapy, Ruhr-Universität Bochum.
Cognitive Behaviour Therapy
Cognitive Behaviour Therapy (CBT) for diagnosed anxiety disorder (i.e. CBT for Panic Disorder in the Panic Disorder group, or other diagnosed anxiety disorders in the Anxious Control group.
Panic Disorder: Waiting list
After the pre-treatment testing session, participants with Panic Disorder randomized to this arm will wait a length of time equivalent to that for the pre/post-treatment duration for the Panic Disorder: Cognitive Behaviour Therapy arm (approx. 3 months), before returning to the post-treatment assessment. After completing all the study procedures, participants in this arm receive also the manualised Cognitive Behaviour Therapy treatment for Panic Disorder, delivered in the outpatient psychotherapy centre of the Department of Clinical Psychology and Psychotherapy, Ruhr-Universität Bochum.
No interventions assigned to this group
Anxious Control Group: CBT
All participants in the Anxious Control Group will receive a manualised Cognitive Behaviour Therapy (CBT) treatment for their diagnosed anxiety disorder, delivered in the outpatient psychotherapy centre of the Department of Clinical Psychology and Psychotherapy, Ruhr-Universität Bochum.
Cognitive Behaviour Therapy
Cognitive Behaviour Therapy (CBT) for diagnosed anxiety disorder (i.e. CBT for Panic Disorder in the Panic Disorder group, or other diagnosed anxiety disorders in the Anxious Control group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Behaviour Therapy
Cognitive Behaviour Therapy (CBT) for diagnosed anxiety disorder (i.e. CBT for Panic Disorder in the Panic Disorder group, or other diagnosed anxiety disorders in the Anxious Control group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary DSM-5 Anxiety Disorder (Panic Disorder for Panic Disorder groups, other anxiety disorder for anxious control group)
* Provided written informed consent
* Patient is in principle able to take part in the therapy
* Sufficient knowledge of German language
* Outpatient (no parallel hospital stay)
* Medical certificate: medical safety, so that hyperventilation is possible
Exclusion Criteria
* Acute suicidality
* Primary affective disorder (e.g. Bipolar I, Major Depression)
* Psychotic disorder
* Parallel psychiatric or psychotherapeutic treatment (acute treatment)
* Current substance dependence (apart from Nicotine dependence)
* Serious medical disorders/ findings
* Other primary treatment diagnosis
* Intellectual impairment (estimated during screening)
* ADHD (estimated during screening)
* Personality disorders
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Research Foundation
OTHER
University of Oxford
OTHER
University of Salzburg
OTHER
Ruhr University of Bochum
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marcella Woud
Postdoctoral Research Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcella L Woud, PhD
Role: PRINCIPAL_INVESTIGATOR
Ruhr University of Bochum
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Psychotherapy Centre, Department of Clinical Psychology and Psychotherapy, Ruhr-Universität Bochum
Bochum, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WO2018/2-1
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
MA1116/13-1
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
145
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.